A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes
|
|||||
|
|
 Comments are closed  Joint ventures/collaborations  biomedical, biotechnology, engineering, equity, genomics, investment, life sciences, venture capital A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, Europe, investment, life sciences, U.K., venture capital The investment opportunities available to us in the modern day? They are large, wide and varied. . . . → Read More: What Does The Future Hold For Investment? The information technology industry is a growing presence in health care, both financially and qualitatively, according to a new report. . . . → Read More: Report: Growing Tech Industry Investment in Health One comment - (Comments are closed) Business conditions, Finance biomedical, computer science, engineering, entrepreneurs, equity, investment, life sciences, medical device, pharmaceuticals, software, venture capital A venture capital company is beginning a $60 million investment fund that plans to finance start-up enterprises providing point-of-care diagnostics and medical treatments. . . . → Read More: Fund Created for Point-of-Care Diagnostics, Treatment Comments are closed Finance biomedical, engineering, entrepreneurs, equity, investment, medical device, software, venture capital A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer. . . . → Read More: Liquid Biopsy Company Gains $360M for Cancer Sequencing Comments are closed Finance, Joint ventures/collaborations biomedical, cancer, equity, investment, Japan, life sciences, medical device, venture capital A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, clinical trials, equity, FDA, investment, licensing, life sciences, pharmaceuticals, venture capital Let’s take a quick look at the ways in which technology has changed the world of investment. . . . → Read More: Technology Has Changed Investing – Here’s How A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round. . . . → Read More: Gene Therapy Start-Up Raises $41M in Early Funds One comment - (Comments are closed) Finance biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital Research and statistical analysis has just as much place in real estate as it does in the sciences. . . . → Read More: The Science Of Property Investment |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
